Showing results (221-230 of 234) with videos related to

Sort By:
Pageof 24
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1989
Quantitative iodine-123 IMP imaging of brain perfusion in schizophreniaM B Cohen, R R Lake, L S Graham, et al.
Kidney International|January 1, 1995
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative StudyM R Rudnick, S Goldfarb, L Wexler, et al.
Cancer Research|September 1, 1986
Arabinosyl-5-azacytosine: mechanisms of native and acquired resistanceG S Ahluwalia, M B Cohen, G J Kang, et al.
The American Journal of Cardiology|October 1, 1993
Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative StudyJ A Hill, M Winniford, M B Cohen, et al.
Cancer Research|May 1, 1997
Fas-mediated apoptosis in human prostatic carcinoma cell linesO W Rokhlin, G A Bishop, B S Hostager, et al.
Cancer|October 1, 1984
Imaging of human tumor xenografts in nude mice with radiolabeled monoclonal antibodies. Limitations of specificity due to nonspecific uptake of antibodyB D Mann, M B Cohen, R E Saxton, et al.
Human Pathology|May 1, 1992
Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitisW D Travis, C H Fox, K O Devaney, et al.
American Journal of Clinical Pathology|May 1, 1995
Pathology and probability. Likelihood ratios and receiver operating characteristic curves in the interpretation of bronchial brush specimensS S Raab, P A Thomas, J C Lenel, et al.
BJU International|December 19, 2000
Biomarker distribution after injection into the canine prostate: implications for gene therapyD R Siemens, T Iwasawa, J C Austin, et al.
Infection and Immunity|November 24, 1999
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccinationC O Tacket, M B Cohen, S S Wasserman, et al.
Pageof 24